Clinical Trial Update: Reducing Cannabis Overuse With Prazosin [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating whether prazosin reduces cannabis overuse in individuals with cannabis use disorder and PTSD has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cannabis Use Disorder
• Posttraumatic Stress Disorder

Drugs mentioned

• Prazosin (prazosin)

Snippet

Sponsor: VA Puget Sound Health Care System | Conditions: Cannabis Dependence, Posttraumatic Stress Disorder | Phase 4 | Status: COMPLETED